In this study, this benefit was evidenced by a reduction in airway inflammatory markers, such as IL-4, IL-5, IL-17A, FeNO and lung function, which consequently resulted in better quality of life and decreased depression levels. This evidence concerns the gene IL4 and depressive symptom measurement.